Latest news with #Real-WorldEvidence
Yahoo
3 days ago
- Health
- Yahoo
Manfred Stapff's Breakthrough Book Hits #1 on Amazon, Tackles Misinformation with Real-World Evidence
Summary: Dr. Manfred Stapff's newly released book, Real-World Evidence Unveiled: Navigating the Maze of Modern Misinformation, has soared to #1 on Amazon in multiple categories. New York, New York--(Newsfile Corp. - June 5, 2025) - Candid-Advisory founder and renowned physician-scientist Dr. Manfred Stapff has made a notable impact in the publishing world with the release of his new book, Real-World Evidence Unveiled: Navigating the Maze of Modern Misinformation. Since its debut on April 23, 2025, the book has become an Amazon bestseller, currently ranked #1 in multiple categories, including Anthropology, Civil Rights and Liberties, Social Theory, Sociology Research and Measurement, Communication Reference, and Social Sciences Research. Image Credit: Real-World Evidence Unveiled by Dr. Manfred Stapff To view an enhanced version of this graphic, please visit: Dr. Stapff's much-needed book has arrived at a time when society is flooded with misleading headlines, viral misinformation, and biased reporting. Through Real-World Evidence Unveiled, he introduces readers to the concept of Real-World Evidence (RWE). This is a powerful approach based on real-life data rather than experimental trials or curated information. Though the term is rooted in healthcare, Stapff broadens its scope to help readers evaluate news, social media narratives, and policy debates through an evidence-based lens. With this book, Stapff refines and filters years of work in regulatory science, quality management, and global medical operations by turning it into an accessible guide for students, professionals, and informed citizens alike. He uses compelling case studies and practical strategies, using the book to show readers the way to distinguish reliable data from noise, break down media narratives, and apply critical thinking in everyday life. Real-World Evidence Unveiled is already earning praise across academic, corporate, and consumer audiences as it continues to climb bestseller charts. The book has become a must-read for anyone interested in truth, transparency, and data-driven thinking. Misinformation prevails in public health, democracy, and social cohesion; Real-World Evidence Unveiled is a warning and a solution. It reminds readers that rigorous thinking and sound data are not just tools for scientists but the foundation of a functional society. About the Author Dr. Manfred Stapff, MD, PhD, is the founder of Candid-Advisory and a leader in clinical research, regulatory science, and real-world data analytics. His career spans over three decades, including senior roles in top pharmaceutical firms across Germany and the United States. He helps individuals and organizations make informed, evidence-based decisions. About Candid-Advisory Candid-Advisory is a life sciences consultancy that offers expert solutions in clinical trials, regulatory affairs, quality management, and real-world data utilization. Headquartered in New York and Boston, the firm partners with healthcare innovators to deliver strategic, unbiased counsel across therapeutic areas and business functions. Media Contact: Company: Candid-AdvisoryPerson: Dr. Manfred StapffEmail: info@ To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
08-04-2025
- Business
- Yahoo
Scientist.com Launches Clinical Labs Navigator™ to Expand Clinical Sourcing Capabilities
New solution streamlines clinical procurement, reduces costs, and accelerates study timelines SAN DIEGO, April 08, 2025--(BUSINESS WIRE)-- the leading R&D procurement orchestration platform for the life sciences, today announced the launch of Clinical Labs Navigator™, a groundbreaking new tool that redefines how clinical trial services are sourced, managed, and executed. Developed in response to growing demand for more modern, collaborative procurement tools, Clinical Labs Navigator enables life science organizations to seamlessly engage with CROs while eliminating the inefficiencies of legacy processes. The platform delivers a more connected and compliant workflow, supporting streamlined communication, full budget digitization, and greater transparency across the clinical research lifecycle. "Clinical Labs Navigator was built to meet the increasing need for integrated, efficient, and compliant solutions in clinical trial execution," said Matt McLoughlin, SVP of Compliance & Categories at "We've created a tool that not only helps clients streamline the design of clinical trials, through enhanced internal and external collaboration, but increases transparency throughout the study design and contracting process." The solution enhances platform workflows across several high-impact areas for both the sponsor and CRO: Budget Digitization: Improved budget tracking and rate card adherence Budget Management: Built-in cost modeling tools to improve and refine accuracy of budget estimates Increased compliance: Enhanced audit trails to increase efficiency and compliance Enhanced analytics: Improved reporting capabilities across various metrics With this release, expands its clinical-stage portfolio to offer solutions across the entire development pipeline including Health Economics and Outcomes Research (HEOR), Real-World Evidence/Data (RWE/RWD), Market Access, GMP manufacturing, and late-stage biomarker development. Clinical Labs Navigator is particularly suited for organizations seeking to consolidate sourcing efforts, reduce study delays, and increase visibility across their global clinical operations. The launch is a key milestone in broader mission to digitally transform the way research is conducted. By leveraging AI-enabled tools and deeply embedded compliance frameworks, the platform empowers researchers and procurement professionals to make smarter, faster decisions—ultimately accelerating the development of life-changing therapies. To learn more about Clinical Labs Navigator™ and explore our full suite of clinical sourcing solutions, visit About is the leading AI-enabled digital research platform for the life science industry. The platform simplifies drug discovery and development by streamlining procurement, accelerating innovation, ensuring regulatory compliance, and connecting researchers with a global network of pre-qualified suppliers. powers private marketplaces for the world's largest pharmaceutical companies, over 100 biotech firms, and the US National Institutes of Health (NIH). Learn more at View source version on Contacts Preci+1 877-644-3044marketing@ Sign in to access your portfolio
Associated Press
08-04-2025
- Business
- Associated Press
Scientist.com Launches Clinical Labs Navigator™ to Expand Clinical Sourcing Capabilities
the leading R&D procurement orchestration platform for the life sciences, today announced the launch of Clinical Labs Navigator™, a groundbreaking new tool that redefines how clinical trial services are sourced, managed, and executed. Developed in response to growing demand for more modern, collaborative procurement tools, Clinical Labs Navigator enables life science organizations to seamlessly engage with CROs while eliminating the inefficiencies of legacy processes. The platform delivers a more connected and compliant workflow, supporting streamlined communication, full budget digitization, and greater transparency across the clinical research lifecycle. 'Clinical Labs Navigator was built to meet the increasing need for integrated, efficient, and compliant solutions in clinical trial execution,' said Matt McLoughlin, SVP of Compliance & Categories at 'We've created a tool that not only helps clients streamline the design of clinical trials, through enhanced internal and external collaboration, but increases transparency throughout the study design and contracting process.' The solution enhances platform workflows across several high-impact areas for both the sponsor and CRO: Budget Digitization: Improved budget tracking and rate card adherence Budget Management: Built-in cost modeling tools to improve and refine accuracy of budget estimates Increased compliance: Enhanced audit trails to increase efficiency and compliance Enhanced analytics: Improved reporting capabilities across various metrics With this release, expands its clinical-stage portfolio to offer solutions across the entire development pipeline including Health Economics and Outcomes Research (HEOR), Real-World Evidence/Data (RWE/RWD), Market Access, GMP manufacturing, and late-stage biomarker development. Clinical Labs Navigator is particularly suited for organizations seeking to consolidate sourcing efforts, reduce study delays, and increase visibility across their global clinical operations. The launch is a key milestone in broader mission to digitally transform the way research is conducted. By leveraging AI-enabled tools and deeply embedded compliance frameworks, the platform empowers researchers and procurement professionals to make smarter, faster decisions—ultimately accelerating the development of life-changing therapies. To learn more about Clinical Labs Navigator™ and explore our full suite of clinical sourcing solutions, visit is the leading AI-enabled digital research platform for the life science industry. The platform simplifies drug discovery and development by streamlining procurement, accelerating innovation, ensuring regulatory compliance, and connecting researchers with a global network of pre-qualified suppliers. powers private marketplaces for the world's largest pharmaceutical companies, over 100 biotech firms, and the US National Institutes of Health (NIH). Learn more at [email protected] SOURCE: Copyright Business Wire 2025. PUB: 04/08/2025 07:55 AM/DISC: 04/08/2025 07:55 AM
Yahoo
29-01-2025
- Business
- Yahoo
Princeton Biopartners Welcomes Dr. Synøve Kamøy as Engagement Manager
NEW YORK, Jan. 29, 2025 /PRNewswire/ -- Princeton Biopartners, a best-in-class provider of integrated consulting solutions to the life sciences sector, proudly announces the appointment of Synøve Kamøy, M.D., as Engagement Manager. This strategic addition to the team underscores the firm's commitment to driving innovation and delivering transformative solutions in Medical Strategy and Real-World Evidence (RWE). Synøve brings a unique combination of medical expertise and strategic insight to the role. She joins Princeton Biopartners following her tenure at Boston Consulting Group (BCG), where she excelled in leading data optimization initiatives that significantly enhanced healthcare organizations' performance. She holds a Medical Doctorate from the University of Oslo, a top European medical institution, and a master's degree in Artificial Intelligence Applications. Synøve's focus as Engagement Manager will be: Driving initiatives in Medical Strategy and Integrated Evidence-Generation Planning (IEGP) Empowering organizations to leverage data-driven solutions that create value, improve outcomes, and achieve transformative impact Building on Princeton's award-winning work and upholding its distinguished 9/10 client satisfaction rating through her commitment to forging lasting client relationships and delivering above-and-beyond results "Advancing Princeton's commitment to building lasting client relationships founded on trust, high-impact deliverables, and an above-and-beyond philosophy resonates deeply with me," says Synøve. "My journey through medicine and management consulting has fueled my passion for healthcare at scale, particularly in driving better decision-making and data utilization to improve access and quality of care. What excites me most about Princeton is its hands-on client approach and the dynamic, close-knit team spirit. As an Engagement Manager, I bring a strong focus on communication and technical excellence, and I look forward to collaborating with my team and clients to deliver meaningful outcomes for patients." Dillon Shokar, Co-Founder and Growth Lead at Princeton Biopartners commented, "Synøve's appointment signals a pivotal step in Princeton Biopartners' evolution as a market-defining leader in Medical Strategy and Integrated Evidence Generation. This move not only accelerates our trajectory across Medical Affairs and Real-World Evidence but also reinforces our commitment to pairing world-class talent with AI-enabled software solutions to unlock unprecedented value. By redefining efficiency and quality standards, we are setting a new paradigm for biopharmaceutical client servicing, one that transforms operations and delivers measurable, patient-centered outcomes. Synøve's deep expertise and methodical approach will be instrumental in empowering our clients to navigate the complexities of an ever-evolving healthcare ecosystem and drive transformative results." About Princeton BiopartnersPrinceton Biopartners is a best-in-class provider of integrated consulting solutions to the life sciences sector. Our mission is to improve the evidence base, accessibility, and dissemination of biomedical innovations through strategic advisory services, software, and our venture fund. We pride ourselves on establishing long-term client relationships and are dedicated to addressing pain points via integrated and transformative projects, setting new standards for excellence and fostering the development of tomorrow's solutions today. Learn more about Princeton Biopartners: Contact Information: contactus@ View original content to download multimedia: SOURCE Princeton Biopartners Sign in to access your portfolio
